JINS HOLDINGS Inc. (JNDOF)
USD 22.75
(0.0%)
USD 22.75
(0.0%)
| Year | Long Term Debt | Long Term Debt Growth |
|---|---|---|
| 2023 | 10.24 Billion JPY | -2.22% |
| 2022 | 10.47 Billion JPY | -49.48% |
| 2021 | 20.73 Billion JPY | -1.87% |
| 2020 | 21.12 Billion JPY | 987.95% |
| 2019 | 1.94 Billion JPY | -4.85% |
| 2018 | 2.04 Billion JPY | -24.04% |
| 2017 | 2.68 Billion JPY | -10.52% |
| 2016 | 3 Billion JPY | 55.3% |
| 2015 | 1.93 Billion JPY | 4.89% |
| 2014 | 1.84 Billion JPY | 5.82% |
| 2013 | 1.74 Billion JPY | -15.74% |
| 2012 | 2.06 Billion JPY | 66.36% |
| 2011 | 1.24 Billion JPY | 118.21% |
| 2010 | 569.5 Million JPY | -26.07% |
| 2009 | 770.34 Million JPY | 755.94% |
| 2008 | 90 Million JPY | 0.0% |
| Year | Long Term Debt | Long Term Debt Growth |
|---|---|---|
| 2024 Q1 | 10.04 Billion JPY | 0.23% |
| 2024 Q3 | 26 Million JPY | -7.14% |
| 2024 Q2 | 28 Million JPY | -99.72% |
| 2023 Q2 | 10.04 Billion JPY | -0.14% |
| 2023 Q3 | 10.03 Billion JPY | -0.1% |
| 2023 Q4 | 10.24 Billion JPY | 2.08% |
| 2023 FY | 10.24 Billion JPY | -2.22% |
| 2023 Q1 | 10.05 Billion JPY | -3.98% |
| 2022 Q4 | 10.47 Billion JPY | 2.74% |
| 2022 FY | 10.47 Billion JPY | -49.48% |
| 2022 Q1 | 20.31 Billion JPY | -2.03% |
| 2022 Q3 | 10.19 Billion JPY | -0.16% |
| 2022 Q2 | 10.21 Billion JPY | -49.73% |
| 2021 Q3 | 20.44 Billion JPY | 0.2% |
| 2021 Q4 | 20.73 Billion JPY | 1.39% |
| 2021 Q1 | 20.45 Billion JPY | -3.19% |
| 2021 FY | 20.73 Billion JPY | -1.87% |
| 2021 Q2 | 20.4 Billion JPY | -0.23% |
| 2020 FY | 21.12 Billion JPY | 987.95% |
| 2020 Q1 | 1.1 Billion JPY | -43.0% |
| 2020 Q4 | 21.12 Billion JPY | 2.98% |
| 2020 Q3 | 20.51 Billion JPY | -4.51% |
| 2020 Q2 | 21.48 Billion JPY | 1840.92% |
| 2019 Q2 | 1.11 Billion JPY | -2.2% |
| 2019 Q3 | 1.16 Billion JPY | 4.68% |
| 2019 Q4 | 1.94 Billion JPY | 66.98% |
| 2019 Q1 | 1.13 Billion JPY | -44.34% |
| 2019 FY | 1.94 Billion JPY | -4.85% |
| 2018 FY | 2.04 Billion JPY | -24.04% |
| 2018 Q2 | 1.4 Billion JPY | -6.2% |
| 2018 Q3 | 1.31 Billion JPY | -6.54% |
| 2018 Q4 | 2.04 Billion JPY | 55.21% |
| 2018 Q1 | 1.5 Billion JPY | -44.18% |
| 2017 Q4 | 2.68 Billion JPY | 62.65% |
| 2017 Q1 | 1.8 Billion JPY | -40.03% |
| 2017 Q2 | 1.7 Billion JPY | -5.27% |
| 2017 Q3 | 1.65 Billion JPY | -3.17% |
| 2017 FY | 2.68 Billion JPY | -10.52% |
| 2016 FY | 3 Billion JPY | 55.3% |
| 2016 Q4 | 3 Billion JPY | 53.92% |
| 2016 Q3 | 1.95 Billion JPY | 86.34% |
| 2016 Q2 | 1.04 Billion JPY | -7.43% |
| 2016 Q1 | 1.13 Billion JPY | -41.51% |
| 2015 Q1 | 1.65 Billion JPY | -10.26% |
| 2015 FY | 1.93 Billion JPY | 4.89% |
| 2015 Q2 | 1.38 Billion JPY | -16.33% |
| 2015 Q3 | 1.15 Billion JPY | -16.83% |
| 2015 Q4 | 1.93 Billion JPY | 67.98% |
| 2014 Q4 | 1.84 Billion JPY | 37.15% |
| 2014 FY | 1.84 Billion JPY | 5.82% |
| 2014 Q3 | 1.34 Billion JPY | -16.51% |
| 2014 Q2 | 1.6 Billion JPY | -15.68% |
| 2014 Q1 | 1.9 Billion JPY | 9.61% |
| 2013 Q2 | 1.47 Billion JPY | -9.92% |
| 2013 Q3 | 1.33 Billion JPY | -9.71% |
| 2013 Q4 | 1.74 Billion JPY | 30.88% |
| 2013 Q1 | 1.63 Billion JPY | -20.84% |
| 2013 FY | 1.74 Billion JPY | -15.74% |
| 2012 Q4 | 2.06 Billion JPY | 23.78% |
| 2012 Q2 | 1.23 Billion JPY | 10.31% |
| 2012 Q1 | 1.11 Billion JPY | -9.89% |
| 2012 Q3 | 1.67 Billion JPY | 35.22% |
| 2012 FY | 2.06 Billion JPY | 66.36% |
| 2011 FY | 1.24 Billion JPY | 118.21% |
| 2011 Q3 | 911.61 Million JPY | 94.69% |
| 2011 Q4 | 1.24 Billion JPY | 36.32% |
| 2011 Q1 | 458.92 Million JPY | -19.42% |
| 2011 Q2 | 468.23 Million JPY | 2.03% |
| 2010 FY | 569.5 Million JPY | -26.07% |
| 2010 Q4 | 569.5 Million JPY | 69.18% |
| 2010 Q3 | 336.63 Million JPY | 0.0% |
| 2009 Q4 | 770.34 Million JPY | 0.0% |
| 2009 Q1 | 371.27 Million JPY | 0.0% |
| 2009 Q2 | 576.03 Million JPY | 55.15% |
| 2009 FY | 770.34 Million JPY | 755.94% |
| 2008 FY | 90 Million JPY | 0.0% |
| Name | Long Term Debt | Long Term Debt Difference |
|---|---|---|
| American Medical Technologies Inc. | - USD | -Infinity% |
| Ansell Limited | 705.27 Million USD | -1352.053% |
| Ansell Limited | 706.6 Million USD | -1349.335% |
| BG Medicine, Inc. | - USD | -Infinity% |
| Biotage AB (publ) | 22.41 Million USD | -45595.162% |
| BioLife Sciences Inc. | - USD | -Infinity% |
| CB Scientific, Inc. | - USD | -Infinity% |
| Psykey, Inc. | 625 Thousand USD | -1638460.0% |
| ConvaTec Group Plc | 1.22 Billion USD | -735.886% |
| ConvaTec Group Plc | 1.22 Billion USD | -734.705% |
| Encision Inc. | 67.33 Thousand USD | -15208703.612% |
| Golden Valley Development, Inc | - USD | -Infinity% |
| Hear AtLast Holdings, Inc. | - USD | -Infinity% |
| Innovative MedTech Inc. | 382.83 Thousand USD | -2674928.798% |
| LifePoint, Inc. | 151.73 Thousand USD | -6749211.295% |
| Medite Cancer Diagnostics, Inc. | 4.91 Million USD | -208304.558% |
| Paradigm Medical Industries, Inc. | 615 Thousand USD | -1665103.252% |
| QuantRx Biomedical Corporation | - USD | -Infinity% |
| Remedent, Inc. | - USD | -Infinity% |
| Reflect Scientific, Inc. | 179.96 Thousand USD | -5690514.182% |
| SmileDirectClub, Inc. | 849.37 Million USD | -1105.704% |
| Sector 10, Inc. | - USD | -Infinity% |
| Shandong Weigao Group Medical Polymer Company Limited | 210.77 Million USD | -4758.623% |
| SheerVision, Inc. | - USD | -Infinity% |
| United Health Products, Inc. | 48.48 Thousand USD | -21120154.078% |
| Vasamed, Inc. | 18.95 Thousand USD | -54042116.359% |
| Wearable Health Solutions, Inc. | 18.46 Thousand USD | -55452574.897% |
| Yubo International Biotech Limited | 390.44 Thousand USD | -2622804.634% |